2016 Hematological Malignancies

HD13: Overall survival All patients (ITT)

0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0

5 year estimate [95%-CI] median obs. time

2xABVD+IF: 2xABV+IF: 2xAVD+IF:

97.4% [95.9% to 98.9%] 94.4% [91.2% to 97.6%] 97.3% [95.9% to 98.8%]

53 m 83 m 55 m

OS

2xAV+IF:

98.3% [96.4% to 100.0%] 82 m

ABVD

ABV

AVD

AV

0

12

24

36

48

60

72

Time [months]

Pts. at Risk

ABVD ABV AVD AV

623 209 620 186

609 206 608 182

590 198 587 180

551 195 550 177

431 187 424 173

298 173 306 164

183 154 191 142